周二盘前交易中，医疗设备制造商丹纳赫（DHR）股价大涨5.16%，引发市场关注。此次涨势主要受公司发布的强劲一季度财报推动。
根据公司公布的数据，丹纳赫第一季度调整后每股收益达1.88美元，大幅超过分析师预期的1.64美元。公司营收也超出预期，达到57.4亿美元，高于分析师预计的55.9亿美元。这一亮眼业绩主要得益于公司呼吸检测试剂盒需求强劲。
尽管面临关税上调可能带来的成本压力，丹纳赫对未来前景保持乐观。公司预计2025年全年调整后每股收益将在7.60美元至7.75美元之间，整体符合市场预期。丹纳赫表示，将通过调整生产布局、优化供应链等措施来应对潜在的关税影响。此外，公司预计2025年剩余时间的终端市场需求将与第一季度保持相对一致，进一步增强了投资者信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.